Abstract 497: Plant viruses against cancer

Abstract

Abstract Immunotherapy has significantly transformed the landscape of cancer treatment; however, concerns about safety, efficacy, and long-term outcomes across various tumor types persist. We have developed an intratumoral immunotherapy strategy with an engineered plant virus nanotechnology and demonstrated efficacy in tumor mouse models and canine cancer patients. This method is designed to elicit a systemic (abscopal effect), safe, and enduring anti-tumor immune response that is not limited by tumor type. The power of immunotherapy lies in synergistic combination treatments and toward this goal, we are engineering the next-generation plant virus nanotechnologies. We demonstrate synergistic combination with chemotherapy and immunization strategies the hone in on tumor-associated antigens and key players of inflammation. The combinatorial immunotherapy strategies prevent recurrence post-surgery in mice and canine patients. We will discuss the engineering design principles leading toward synergetic combination immunotherapies to treat and prevent cancer; efficacy studies and underlying mechanism is elucidated through immunomics studies. Selected references: Steinmetz N.F. et al (2023) Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis. Proc. Natl. Acad. Sci. U.S.A. 120 (43) e2221859120. Wang C. and Steinmetz N.F. (2020) A Combination of Cowpea mosaic virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models. Advanced Functional Materials, 2002299. Citation Format: Nicole F. Steinmetz, Young Hun Chung, Miguel Moreno-Gonzalez, Zhongchao Zhao. Plant viruses against cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 497.